Jeff Lagasse
With specialty drug costs projected to reach $505 billion by 2023 by the company's estimates, Optum has tapped into a potential market opportunity.
The organization hopes the collaboration will speed along development of a more data-driven, personalized customer experience.
HIMSS21
Integrating clinical, claims data key in one Delaware organization's response to COVID-19
HIMSS21
The ailments, approaches and technology are different, but telehealth is alive and well aboard the International Space Station.
HIMSS21
Total hip and knee replacement bundles from CMS spurred the risk-bearing system to seek a new way to maximize savings.
HIMSS21
A pilot telehealth program in Missouri has decreased absences and educated the community on the benefits of virtual health technology.
HIMSS21
The COVID-19 pandemic has resulted in a sense of isolation for many, which underscores the importance of humanization.
HIMSS21
Engaging more with user bases and thinking of patients as consumers is a necessity for those looking to compete for attention with streaming giants.
HIMSS21 Digital
Some of these changes have presented opportunities for entrepreneurs and product developers.
HIMSS21
Technology can enhance the patient experience, but it requires organizational buy-in and an infrastructure that scales.